ZA933178B - Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration - Google Patents
Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administrationInfo
- Publication number
- ZA933178B ZA933178B ZA933178A ZA933178A ZA933178B ZA 933178 B ZA933178 B ZA 933178B ZA 933178 A ZA933178 A ZA 933178A ZA 933178 A ZA933178 A ZA 933178A ZA 933178 B ZA933178 B ZA 933178B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- rectal administration
- pharmaceutical compositions
- receptor agonists
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929209882A GB9209882D0 (en) | 1992-05-07 | 1992-05-07 | Compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA933178B true ZA933178B (en) | 1994-01-10 |
Family
ID=10715158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA933178A ZA933178B (en) | 1992-05-07 | 1993-05-06 | Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration |
Country Status (33)
Country | Link |
---|---|
US (1) | US5705506A (pt) |
EP (1) | EP0639072B1 (pt) |
JP (1) | JPH07506570A (pt) |
KR (1) | KR100253111B1 (pt) |
AT (1) | ATE163850T1 (pt) |
AU (1) | AU670083B2 (pt) |
BE (1) | BE1007024A5 (pt) |
BG (1) | BG62120B1 (pt) |
BR (1) | BR1100108A (pt) |
CA (1) | CA2135179C (pt) |
CH (1) | CH685920A5 (pt) |
CY (1) | CY2039B1 (pt) |
CZ (1) | CZ283512B6 (pt) |
DE (1) | DE69317418T2 (pt) |
ES (1) | ES2113533T3 (pt) |
FR (1) | FR2690847B1 (pt) |
GB (2) | GB9209882D0 (pt) |
GR (1) | GR3026584T3 (pt) |
HK (1) | HK95697A (pt) |
HU (2) | HU227338B1 (pt) |
IE (1) | IE75203B1 (pt) |
IL (1) | IL105468A (pt) |
IT (1) | IT1261471B (pt) |
NO (1) | NO306700B1 (pt) |
NZ (1) | NZ252132A (pt) |
OA (1) | OA10109A (pt) |
RO (1) | RO112993B1 (pt) |
RU (1) | RU2118527C1 (pt) |
SG (1) | SG46649A1 (pt) |
TW (1) | TW231970B (pt) |
UA (1) | UA37206C2 (pt) |
WO (1) | WO1993021916A1 (pt) |
ZA (1) | ZA933178B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997044062A1 (en) * | 1996-05-23 | 1997-11-27 | Alcon Laboratories, Inc. | The use of 5-ht1b/1d agonists to treat ocular pain |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
ATE464900T1 (de) * | 1998-03-26 | 2010-05-15 | Astellas Pharma Inc | Retardpräparat mit makroliden wie tacrolimus |
US7704958B1 (en) * | 1999-03-05 | 2010-04-27 | Bio Holding, Inc. | Methods and compositions for inhibiting apoptosis using serine protease inhibitors |
JP2010522135A (ja) | 2006-10-09 | 2010-07-01 | チャールストン ラボラトリーズ,インコーポレイテッド | 医薬組成物 |
EP2240022B1 (en) | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
CA2767576C (en) | 2009-07-08 | 2020-03-10 | Charleston Laboratories Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
CN103402514B (zh) | 2010-10-15 | 2016-01-13 | 康特拉医药公司 | 用于治疗运动障碍的血清素受体激动剂组合物 |
JP6216768B2 (ja) | 2012-04-18 | 2017-10-18 | コンテラ ファーマ アンパルトセルスカブContera Pharma Aps | 運動障害の管理の改善に適した経口投与可能な医薬製剤 |
JP2019507181A (ja) | 2016-03-04 | 2019-03-14 | チャールストン ラボラトリーズ,インコーポレイテッド | 医薬組成物 |
US11975104B2 (en) | 2016-07-11 | 2024-05-07 | Contera Pharma A/S | Pulsatile drug delivery system for treating morning akinesia |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2083463B (en) * | 1980-08-12 | 1984-05-10 | Glaxo Group Ltd | Heterocyclic compounds |
GB2082175B (en) * | 1980-08-12 | 1984-05-02 | Glaxo Group Ltd | Heterocyclic compounds |
ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
IT1170387B (it) * | 1982-06-07 | 1987-06-03 | Glaxo Group Ltd | Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono |
GB8332435D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
AU584142B2 (en) * | 1984-12-04 | 1989-05-18 | Glaxo Group Limited | Indole derivatives |
GB8431426D0 (en) * | 1984-12-13 | 1985-01-23 | Glaxo Group Ltd | Chemical compounds |
US4833153A (en) * | 1985-11-08 | 1989-05-23 | Glaxo Group Limited | Indole derivatives |
KR0131327B1 (en) * | 1987-08-13 | 1998-04-17 | Glaxo Group Ltd | Indole derivatives |
HU219974B (hu) * | 1990-06-07 | 2001-10-28 | Astrazeneca Ab, | Heterociklusos csoporttal helyettesített indolszármazék, előállítása és a vegyületet hatóanyagként tartalmazó gyógyszerkészítmények |
-
1992
- 1992-05-07 GB GB929209882A patent/GB9209882D0/en active Pending
-
1993
- 1993-04-20 IL IL10546893A patent/IL105468A/en not_active IP Right Cessation
- 1993-05-03 RU RU94046069/14A patent/RU2118527C1/ru not_active IP Right Cessation
- 1993-05-03 AU AU40640/93A patent/AU670083B2/en not_active Ceased
- 1993-05-03 US US08/331,485 patent/US5705506A/en not_active Expired - Fee Related
- 1993-05-03 RO RO94-01790A patent/RO112993B1/ro unknown
- 1993-05-03 EP EP93909884A patent/EP0639072B1/en not_active Expired - Lifetime
- 1993-05-03 DE DE69317418T patent/DE69317418T2/de not_active Expired - Lifetime
- 1993-05-03 JP JP5518928A patent/JPH07506570A/ja active Pending
- 1993-05-03 ES ES93909884T patent/ES2113533T3/es not_active Expired - Lifetime
- 1993-05-03 HU HU9403188A patent/HU227338B1/hu unknown
- 1993-05-03 AT AT93909884T patent/ATE163850T1/de active
- 1993-05-03 CA CA002135179A patent/CA2135179C/en not_active Expired - Fee Related
- 1993-05-03 UA UA94115989A patent/UA37206C2/uk unknown
- 1993-05-03 CZ CZ942723A patent/CZ283512B6/cs not_active IP Right Cessation
- 1993-05-03 WO PCT/EP1993/001077 patent/WO1993021916A1/en active IP Right Grant
- 1993-05-03 NZ NZ252132A patent/NZ252132A/en not_active IP Right Cessation
- 1993-05-05 GB GB9309209A patent/GB2266665B/en not_active Expired - Lifetime
- 1993-05-05 SG SG1996007136A patent/SG46649A1/en unknown
- 1993-05-06 IE IE930339A patent/IE75203B1/en not_active IP Right Cessation
- 1993-05-06 ZA ZA933178A patent/ZA933178B/xx unknown
- 1993-05-06 FR FR9305432A patent/FR2690847B1/fr not_active Expired - Lifetime
- 1993-05-06 BE BE9300467A patent/BE1007024A5/fr not_active IP Right Cessation
- 1993-05-06 IT ITRM930286A patent/IT1261471B/it active IP Right Grant
- 1993-05-06 CH CH139793A patent/CH685920A5/fr not_active IP Right Cessation
- 1993-05-12 TW TW082103742A patent/TW231970B/zh active
-
1994
- 1994-11-04 OA OA60578A patent/OA10109A/en unknown
- 1994-11-04 NO NO944214A patent/NO306700B1/no not_active IP Right Cessation
- 1994-11-05 KR KR1019940703950A patent/KR100253111B1/ko not_active IP Right Cessation
- 1994-11-07 BG BG99167A patent/BG62120B1/bg unknown
-
1995
- 1995-06-29 HU HU95P/P00531P patent/HU211638A9/hu unknown
-
1996
- 1996-12-24 BR BR1100108-9A patent/BR1100108A/pt active IP Right Grant
-
1997
- 1997-06-26 HK HK95697A patent/HK95697A/xx not_active IP Right Cessation
-
1998
- 1998-04-10 GR GR980400773T patent/GR3026584T3/el unknown
- 1998-04-30 CY CY9802039A patent/CY2039B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6750996A (en) | Oral fast-dissolving compositions for dopamine agonists | |
ATE331726T1 (de) | Adenine-derivate | |
AP2001002129A0 (en) | 5HT1 receptor agonists and metoclopramide for the treatment of migrane. | |
MY117274A (en) | Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present. | |
MX9702865A (es) | Agentes estrogenicos. | |
MY136249A (en) | Phenylethanolamine compounds as anti-obesity agents | |
ZA971279B (en) | Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors | |
ZA933178B (en) | Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration | |
YU2603A (sh) | Nova kombinacija (5ht2) agonista i (5ht6) antagonista serotonina kao farmaceutska kombinacija | |
IL114600A (en) | Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them | |
IL114598A (en) | Triazole compounds their preparation and pharmaceutical compositions containing them | |
GR3022615T3 (en) | Pharmaceutical compositions based on ebastime or analogues thereof. | |
WO2000000198A8 (en) | Piperidine derivatives having effects on serotonin related systems | |
EP1064966A3 (en) | Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine | |
GR3036195T3 (en) | Novel compounds | |
BG102229A (en) | Endothelium receptor antagonists | |
EP1064948A3 (en) | Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine | |
EP1051994A3 (en) | 5HT1 receptor agonists and a COX-2 inhibitor for the treatment of migraine |